Male infertility arises from impaired spermatogenesis (low count, motility, or morphology), obstructive azoospermia, ejaculatory dysfunction, or testicular tissue damage — often multifactorial in aetiology.
Male infertility arises from impaired spermatogenesis (low count, motility, or morphology), obstructive azoospermia, ejaculatory dysfunction, or testicular tissue damage — often multifactorial in aetiology. Stem-cell research investigates whether placental mesenchymal stem cells and fetal stem cells can regenerate spermatogenic epithelium, restore Sertoli- and Leydig-cell function, and promote testicular tissue recovery after chemotherapy, trauma, or infection. With 15 registered trials and 3 currently recruiting, the therapeutic scope is narrower than systemic conditions but biologically compelling: testicular microenvironment regeneration could restore fertility. Early preclinical and clinical data suggest potential for improving semen parameters, increasing testosterone production, and potentially recovering spermatogenesis in select azoospermic men.
| עלות מעריכה · בולגריה (EU) | €3,000–€8,000 |
|---|---|
| טווח עלויות השוק הגלובלי | €7,000–€25,000 (dvcstem.com) |
| סוגי התאים העיקריים שנחקרו | MSCs from Amniotic Membrane, Fetal Stem Cells |
| סטטוס אישור | ניסיוני |
| ניסויים רשומים (ClinicalTrials.gov) | 15 · 3 recruiting now |
For the clinic's own description, see how Stem Plus describes its Male Infertility programme ↗.
Male infertility trials are the smallest cohort among studied conditions, reflecting disease prevalence and therapeutic complexity. Three actively recruiting studies indicate emerging clinical interest. Published data predominantly come from small preclinical and early-phase clinical series. Some trials documented improvements in semen parameters (sperm concentration, motility, morphology) following MSC infusion into testicular tissue; a few azoospermic patients recovered some spermatogenesis permitting natural conception or assisted reproduction. Testosterone levels increased in responsive cohorts, suggesting Leydig-cell regeneration. However, study heterogeneity, small sample sizes, and limited controls restrict conclusions. Mechanism studies support germ-cell niche regeneration, but direct in-vivo confirmation in humans remains incomplete. Long-term paternity outcomes are inadequately documented.
Depending on assessment, a Male Infertility protocol may draw on:
Male infertility stem-cell treatment costs typically range €4,000–7,500 per cycle, reflecting the need for testicular biopsy-guided injection or tissue regeneration protocols. Placental MSCs and fetal stem cells incur manufacturing costs; cell dose is often higher than systemic conditions due to target-tissue penetration challenges. Single-infusion protocols predominate, though repeat treatments may be considered 3–6 months after initial therapy if improvement is partial. Sperm cryopreservation and ongoing semen-parameter testing add €500–1,500 to total cost. European andrology centres (Germany, Spain, Italy, Poland) typically charge €4,000–6,000; private boutique fertility clinics may exceed €7,500. Coordination with reproductive medicine may add additional consultation costs.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Male Infertility cost-by-country breakdown, or compare the best countries for Male Infertility →
Before booking, check safety & regulation, the recovery climate, אם אתה עשוי להיות מועמד, and which cell type fits Male Infertility.
שאלות תשובות אי פוריות זכרית מלאות → · פירוט עלויות אי פוריות זכרית →
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: האם אני מועמד? · איזה סוג תאים? · Types of clinics & best countries · מחשבון עלויות
בדוקה רפואית על ידי צוות העריכה של StemCellAtlas עם Dr Dmytro Stoyanov (Urologist · 31+ yrs clinical practice) של קליניקת השותף Stem Plus (סופיה), כנגד הנחיות ISSCR, FDA ו-EMA. Educational information, not medical advice; figures indicative.
רפואה רגנרטיבית מאושרת GMP בלב האיחוד האירופי — החל מ-3,000–8,000 יורו, חלק קטן ממחירי ארהב או גרמניה. פרוטוקולים מותאמים אישית למטופלים מ-50+ מדינות.
בדיקה רפואית חינם